|
Aliasger K. Salem is the Bighley Professor of Pharmaceutical Sciences and Head of the Division of Pharmaceutics and Translational Therapeutics at the University of Iowa College of Pharmacy. Salem's primary appointment at the University of Iowa is based in the College of Pharmacy,〔(Salem, Aliasger | University of Iowa College of Pharmacy )〕 with additional secondary appointments in the College of Dentistry, Department of Chemical and Biochemical Engineering, Department of Biomedical Engineering,〔(Secondary Faculty (CBE) | Department of Chemical and Biochemical Engineering )〕〔(Affiliated Faculty | Department of Biomedical Engineering )〕 and the Holden Comprehensive Cancer Center.〔(Executive Committee :: About Holden )〕 Salem was an American Cancer Society Research Scholar from 2009 to 2013.〔(Pharmacy researcher to use American Cancer Society grant for melanoma research )〕 Salem is currently the leader of the Experimental Therapeutics (ET) program at the Holden Comprehensive Cancer Center.〔(Cancer Signaling and Experimental Therapeutics Program :: Cancer Research )〕 Aliasger Salem is the Associate Editor for The AAPS Journal - The official journal of the American Association for Pharmaceutical Scientists〔(The AAPS Journal (Associate Editor) )〕 and an editorial board member for a number of other journals including the International Journal of Pharmaceutics.〔(International Journal of Pharmaceutics Editorial Board )〕 Aliasger Salem has been or is a member of a number of grant review study sections including panels for the American Cancer Society,〔(【引用サイトリンク】title=Peer Review Committee for Cancer Drug Discovery (CDD) )〕 the National Institutes of Health, the National Science Foundation, and the Department of Defense (DoD): Congressionally Directed Medical Research Programs (CDMRP) Prostate and Breast Cancer Research Programs. Salem has received a number of teaching awards including a Council of Teaching Instructional Improvement Award in 2008 and a Collegiate Teacher of the Year award in 2012.〔(Teaching award-winner Salem encourages active learning | Iowa Now - The University of Iowa )〕 Prior to joining the University of Iowa in 2004, he was a postdoctoral fellow at the Johns Hopkins School of Medicine and completed his PhD at the School of Pharmacy and Pharmaceutical Sciences at the University of Nottingham in the UK. Salem's research interests 〔(Aliasger Salem - Google Scholar Citations )〕〔(salem ak - PubMed - NCBI )〕 include nanotechnology, microfabrication, particle and drug delivery systems,〔(Nitrogen-Sulfur Polymers Break New Ground | Chemical & Engineering News )〕 implantable chips,〔(【引用サイトリンク】title=UI Researchers Working on Microchip Pharmacies’ )〕 the design of gene delivery systems,〔(Special Delivery: Metallic nanorods shuttle genes | Technology | Science News )〕〔(Nature view )〕 〔(Silicalite nanoparticles promote transgene expression - nanotechweb.org )〕 regenerative medicine,〔(【引用サイトリンク】title=UI Researchers Develop )〕〔(【引用サイトリンク】title=New 'bio patch' can successfully grow damaged or missing bone tissue )〕 and the development of vaccines.〔(Researchers Aim to Develop Cancer Vaccines | News | Drug Discovery and Development Magazine )〕〔(【引用サイトリンク】title=Nanoparticles in Vaccine Delivery )〕〔(【引用サイトリンク】title=University of Iowa Working on Dust Mite Allergy Vaccine )〕〔(【引用サイトリンク】title=Pharmacy, medicine researchers get grant )〕 == Selected Honors and Awards== *2014 Associate Editor, The AAPS Journal - The Official Journal of the American Association for Pharmaceutical Scientists *2013 Lyle and Sharon Bighley Endowed Professor of Pharmaceutical Sciences *2009 American Cancer Society Research Scholar Award *2005 The Pharmaceutical Research and Manufacturers of America Foundation Award 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Aliasger K. Salem」の詳細全文を読む スポンサード リンク
|